Skip to main content
. 2021 Sep 14;19(9):1606–1616. doi: 10.2174/1570159X19666210113144703

Fig. (2).

Fig. (2)

Mechanisms of action of saffron extracts for the treatment of Alzheimer’s disease from preclinical studies. ROS, reactive oxygen species; AChE-I, acetylcholinesterase inhibitors; BBB, blood–brain barrier; NMDA, N-methyl-D-aspartate receptor; Anti-Aβ, anti-beta amyloid. (A higher resolution / colour version of this figure is available in the electronic copy of the article).